Amazon Com Inc holds a concentrated book of 5 stocks worth $2.6B as of Q1 2026 (disclosed May 5, 2026, a ~45-day 13F lag). Their largest long position is Rivian Automotive Inc-A at 91% of the equity book.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
This fund page is the Follow view. The Build view lets your agent pull holdings, quarter changes, overlap, and source filings through API or MCP.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/funds/1018724/holdings"
Use Arkolith to show AMAZON COM INC's latest holdings, largest changes, and filing provenance.
Top-heavy: concentrated book
Share of the disclosed book in its largest positions. A higher top-5 share means a more concentrated, higher-conviction portfolio.
100% mapped to company sectors
Direct operating-company sectors from our SIC-based security master. ETF/fund and unclassified holdings stay visible separately; this is not ETF look-through exposure.
Estimated $ traded · quarter-end prices, no cost basis
Bars show each stock's share of the portfolio. Click a row for its position history.
| # | Security | Value | Shares | % Port | Last move | History |
|---|---|---|---|---|---|---|
| 1 | Rivian Automotive Inc COM CL A | $2.4B | 158.36M | 90.6% | —Held | |
| 2 | Beta Technologies Inc COM SHS CL A | $172.8M | 11.75M | 6.6% | —Held | |
| 3 | Marvell Technology Inc COM | $39.3M | 396.4K | 1.5% | ▲+76% Added · +171K sh | |
| 4 | Astera Labs Inc COM | $30.4M | 277.8K | 1.2% | —Held | |
| 5 | Nautilus Biotechnology Inc COM | $5.7M | 1.46M | 0.2% | —Held |
As-of date vs the date the SEC received each filing
| Quarter | As of | Filed | Positions | Value | Form |
|---|---|---|---|---|---|
| Q1 2026 | Mar 31, 2026 | May 5, 2026 | 5 | $2.6B | 13F-HR |
| Q4 2025 | Dec 31, 2025 | Feb 10, 2026 | 6 | $3.5B | 13F-HR |
| Q3 2025 | Sep 30, 2025 | Nov 4, 2025 | 7 | $2.5B | 13F-HR |
| Q2 2025 | Jun 30, 2025 | Aug 5, 2025 | 9 | $2.4B | 13F-HR |
| Q1 2025 | Mar 31, 2025 | May 6, 2025 | 9 | $2.4B | 13F-HR |
| Q4 2024 | Dec 31, 2024 | Feb 7, 2025 | 9 | $2.7B | 13F-HR |
| Q3 2024 | Sep 30, 2024 | Nov 7, 2024 | 10 | $2.2B | 13F-HR |
| Q2 2024 | Jun 30, 2024 | Jul 30, 2024 | 10 | $2.5B | 13F-HR |
| Q1 2024 | Mar 31, 2024 | Apr 29, 2024 | 10 | $2.1B | 13F-HR |
| Q4 2023 | Dec 31, 2023 | Jan 30, 2024 | 9 | $4.1B | 13F-HR |
| Q3 2023 | Sep 30, 2023 | Oct 18, 2023 | 9 | $4.3B | 13F-HR |
| Q2 2023 | Jun 30, 2023 | Jul 27, 2023 | 9 | $3.1B | 13F-HR |
| Q1 2023 | Mar 31, 2023 | May 1, 2023 | 8 | $2.8B | 13F-HR |
| Q4 2022 | Dec 31, 2022 | Jan 18, 2023 | 8 | $3.3B | 13F-HR |
| Q3 2022 | Sep 30, 2022 | Oct 19, 2022 | 9 | $5.6B | 13F-HR |
| Q2 2022 | Jun 30, 2022 | Aug 2, 2022 | 9 | $4.5B | 13F-HR |
| Q1 2022 | Mar 31, 2022 | May 5, 2022 | 10 | $8.5B | 13F-HR |
| Q4 2021 | Dec 31, 2021 | Feb 2, 2022 | 11 | $17.0B | 13F-HR |
| Q3 2021 | Sep 30, 2021 | Oct 29, 2021 | 7 | $490.2M | 13F-HR |
| Q2 2021 | Jun 30, 2021 | Jul 28, 2021 | 3 | $381.9M | 13F-HR |
| Q1 2021 | Mar 31, 2021 | May 10, 2021 | 2 | $60.3M | 13F-HR |
| Q4 2020 | Dec 31, 2020 | Feb 11, 2021 | 1 | $40.6M | 13F-HR |
Holdings from SEC EDGAR 13F-HR filings, updated quarterly ~45 days after quarter-end. Public domain. The book and weighting are long equity only; disclosed put/call options are listed separately and excluded from those totals. Price-derived performance is withheld until the price-source policy and freshness gate are green.